Stocks
AXIM Biotechnologies, Inc.AXIM
OIDHealthcareBiotechnology$0.00
Price as of · delayed, not real-time
A clinical-stage biopharmaceutical company developing cannabinoid-based therapies for conditions such as pain, inflammation, and neurological disorders. Its pipeline includes drug candidates in various stages of preclinical and clinical development, and investors track it for its exposure to the emerging cannabinoid pharmaceutical market.
52W Range: $0.00-$0.03
Congressional Interest in AXIM Biotechnologies, Inc. (AXIM)
No congressional trades have been disclosed for AXIM Biotechnologies, Inc. (AXIM) yet. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
0
Unique Politicians
0
Buys
0
Sells
0
Who in Congress Is Trading AXIM?
No congressional trades found for this stock.